Bone mineral density significantly decreases during and after menopause due to dropping levels of estrogen. Historically, estrogen therapy has been prescribed to help protect bones, but a new study suggests that the addition of testosterone therapy may improve results compared with using estrogen alone. Results of the study were presented at the 2026 Annual Meeting of The Menopause Society in San Diego Oct. 20–24, 2026.
Combined Estrogen and Testosterone Therapy Enhances Bone Health in Postmenopausal Women
A study presented at the 2026 Annual Meeting of The Menopause Society indicates that combined estrogen and testosterone therapy can significantly improve lumbar spine bone mineral density in postmenopausal women. This research may influence healthcare practices in Iran regarding menopause treatment. Improved bone health is crucial for the aging population in Iran, where women's health issues are increasingly prioritized.
👥 Key Players
📰 What Happened
A study presented at The Menopause Society's annual meeting found that combining estrogen and testosterone therapy can significantly enhance bone health in postmenopausal women. This suggests a potential shift in treatment practices.
- Bone mineral density decreases significantly during and after menopause due to lower estrogen levels.
- The study indicates that testosterone therapy may improve bone density outcomes compared to estrogen therapy alone.
💡 Why It Matters
📚 Background
Postmenopausal women experience significant health challenges, particularly related to bone density, due to hormonal changes. Hormone replacement therapies have been a focus of research to mitigate these effects.
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%